Population Pharmacokinetic/Pharmacodynamic Analyses as the Basis for Dosing of Therapeutic Monoclonal Antibodies

被引：4
|
作者：
Meibohm, Bernd [1 ]
机构：
[1] Univ Tennessee, Ctr Hlth Sci, Coll Pharm, Memphis, TN 38163 USA
来源：
CLINICAL PHARMACOKINETICS | 2011年 / 50卷 / 12期
关键词：
MODEL;
D O I：
10.2165/11597950-000000000-00000
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：823 / 824
页数：2
相关论文
共 50 条
  • [31] Guidelines for the Quality Control of Population Pharmacokinetic–Pharmacodynamic Analyses: an Industry Perspective
    P. L. Bonate
    A. Strougo
    A. Desai
    M. Roy
    A. Yassen
    J. S. van der Walt
    A. Kaibara
    S. Tannenbaum
    The AAPS Journal, 2012, 14 : 749 - 758
  • [32] Population pharmacokinetic and pharmacodynamic analyses of safinamide in subjects with Parkinson's disease
    Loprete, Luca
    Leuratti, Chiara
    Cattaneo, Carlo
    Thapar, Mita M.
    Farrell, Colm
    Sardina, Marco
    PHARMACOLOGY RESEARCH & PERSPECTIVES, 2016, 4 (05):
  • [33] Cancer Immunotherapy Dosing: A Pharmacokinetic/Pharmacodynamic Perspective
    Le Louedec, Felicien
    Leenhardt, Fanny
    Marin, Clemence
    Chatelut, Etienne
    Evrard, Alexandre
    Ciccolini, Joseph
    VACCINES, 2020, 8 (04) : 1 - 23
  • [34] Optimal Dosing of Ceftriaxone in Infants Based on a Developmental Population Pharmacokinetic-Pharmacodynamic Analysis
    Wang, Ya-Kun
    Wu, Yue-E
    Li, Xue
    Tian, Li-Yuan
    Khan, Muhammad Wasim
    Tang, Bo-Hao
    Shi, Hai-Yan
    Zheng, Yi
    Hao, Guo-Xiang
    van den Anker, John
    You, Dian-Ping
    Zhao, Wei
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2020, 64 (11)
  • [35] Evaluation of omadacycline dosing regimens in Chinese using population pharmacokinetic-pharmacodynamic analysis
    Wang, Kun
    Zhu, Yusong
    Xu, Fengyan
    Liu, Lucy
    Liu, Lichuan
    Shi, Mengling
    Nie, Jing
    Reinhart, Harald
    Liu, Jing
    Gao, Yuying
    Pu, Xia
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2024, 195
  • [36] Ribavirin dosing in chronic hepatitis C: Application of population pharmacokinetic-pharmacodynamic models
    Jen, J
    Laughlin, M
    Chung, C
    Heft, S
    Affrime, MB
    Gupta, SK
    Glue, P
    Hajian, G
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2002, 72 (04) : 349 - 361
  • [37] Population pharmacokinetic and pharmacodynamic analyses of teicoplanin in Japanese patients with systemic MRSA infection
    Ogawa, Ryuichi
    Kobayashi, Seiichi
    Sasaki, Yuki
    Makimura, Mizue
    Echizen, Hirotoshi
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2013, 51 (05) : 357 - 366
  • [38] Guidelines for the Quality Control of Population Pharmacokinetic-Pharmacodynamic Analyses: an Industry Perspective
    Bonate, P. L.
    Strougo, A.
    Desai, A.
    Roy, M.
    Yassen, A.
    van der Walt, J. S.
    Kaibara, A.
    Tannenbaum, S.
    AAPS JOURNAL, 2012, 14 (04): : 749 - 758
  • [39] Population pharmacokinetic and pharmacokinetic/pharmacodynamic modeling of istradefylline
    Rao, Niranjan
    Knebel, William
    Gastonguay, Marc
    Uchimura, Tatsuo
    Bergsma, Tim
    Mori, Akihisa
    NEUROLOGY, 2008, 70 (11) : A60 - A60
  • [40] Population pharmacokinetic and pharmacodynamic analyses of ribavirin in patients with chronic hepatitis C.
    Jen, CJF
    Laughlin, M
    Chung, C
    Heft, S
    Affrime, MB
    Hajian, G
    HEPATOLOGY, 2001, 34 (04) : 599A - 599A
12345